From science to story—make your asset partnerable and investment-ready.
Strong data isn’t enough. To attract partners or investors, biotech programs need to be framed with clear market logic, strategic differentiation, and a compelling value proposition. At JRC, we help you shape the commercial narrative behind your science—ensuring your program resonates with BD teams, payers, and capital markets.
Target Product Profile (TPP) & Value Framing
We help define a product vision that connects clinical attributes with commercial potential.
- TPP development aligned with clinical, regulatory, and market endpoints
- Product value proposition and positioning strategy
- Disease burden, unmet need, and market segmentation analysis
- Input to proof-of-concept and pivotal trial design
Pricing, Access & Market Strategy
We support market entry and payer engagement planning from the earliest stages.
- Value-based pricing frameworks
- U.S. and ex-U.S. payer research coordination
- Health economic and budget impact modeling
- Indication sequencing and lifecycle strategy
Investor & Licensing Preparation
We turn your program data and strategy into a story investors and partners can understand—and act on.
- Investor and BD pitch deck development
- Clinical and commercial milestone mapping
- Asset positioning for partnering conversations
- Custom messaging for MNC licensing teams
What Makes Us Different
- Strategy shaped by real-world payer and partner feedback
- Hands-on, investor-ready content development
-
Experience bridging R&D and market access logic